Delivery Order SPE2DB22D3016-SPE2DB26FAAE6
- Not listed
- The Defense Logistics Agency awarded a $87,253.24 delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. This firm fixed-price, non-set-aside contract is set to be completed by November 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger contract vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product, with a ceiling value of $23,920.84 and an ultimate completion date of September 23, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $23,920.84 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product to be delivered to Conshohocken, Pennsylvania by August 18, 2025. This competitive award, issued under a firm fixed-price delivery order contract with no set-aside designation, represents a single transaction on AmerisourceBergen's larger pharmaceutical supply agreement with the agency. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $17,940.63 to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical products. This firm fixed price delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialized pharmaceutical product. This competitive, non-set-aside delivery order carries a firm fixed price ceiling value of $95,683.36 with an ultimate completion date of July 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $123,315.90 for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product on September 19, 2025, with an ultimate completion date of October 10, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $166,845.06 delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This firm fixed-price delivery order, valued at $23,920.84, represents a non-competitive set-aside transaction and is set to conclude by September 22, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting the federal government's medical supply chain...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This firm fixed-price delivery order, valued at $59,802.10, represents a competitive award with no set-aside designation and is scheduled for completion by October 3, 2025. The product will be delivered to the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $23,920.84 delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML, a specialized pharmaceutical product, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a single delivery order issued under AmerisourceBergen's existing...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FAAE6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product. This firm fixed price delivery order, valued at $17,940.60, is scheduled for completion by November 10, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's capability to compete in open federal procurement processes. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical distributor, AmerisourceBergen serves critical medical supply needs for military healthcare systems and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. The company's comprehensive contract vehicle enables flexible supply of a broad range of pharmaceutical products, specialty medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.9k | 10/20/25 |